title: ASHP therapeutic position statement on the role of pharmacotherapy in preventing venous thromboembolism in hospitalized patients.
authors.affiliation: New Mexico Heart Institute, Albuquerque, NM, USA. cmahan@nmhi.com
authors.forename: Charles E
authors.initials: CE
authors.lastname: Mahan
authors.forename: Alex C
authors.initials: AC
authors.lastname: Spyropoulos
mesh_terms: D020000:Decision Support Systems, Clinical; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007297:Inpatients; D011183:Postoperative Complications / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D019984:Quality Indicators, Health Care; D018570:Risk Assessment; D012307:Risk Factors; D012957:Societies, Pharmaceutical; D014481:United States; D054556:Venous Thromboembolism / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents